Clinical Trial Update: Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for gefapixant (MK-7264) in adult Japanese participants with unexplained or refractory chronic cough; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• Gefapixant (gefapixant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Cough | Phase 2 | Status: COMPLETED | Results posted: 2019-07-05